A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

In the United States, prescriptions for weight-loss drugs for teens have increased 600 per cent, according to one study. But ...